Determination of mycophenolic acid and its phenyl glucuronide in human plasma, ultrafiltrate, blood, DBS and dried plasma spots

Bioanalysis

Volumn 2, Issue 8, 2010, Pages 1423-1435

  Heinig, Katja ^a   Bucheli, Franz ^a   Hartenbach, Roswitha ^a   Gajate Perez, Almudena ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE; GLUCURONIDE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID PHENYL GLUCURONIDE; UNCLASSIFIED DRUG; GLUCURONIC ACID; PHENYL GLUCURONIDE;

ACCURACY; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRIED BLOOD SPOT; DRUG DETERMINATION; DRUG STABILITY; DRUG STRUCTURE; HIGH THROUGHPUT SCREENING; HUMAN; ISOTOPE LABELING; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; NONHUMAN; ONLINE ANALYSIS; QUALITY CONTROL; SENSITIVITY AND SPECIFICITY; SPECIES DIFFERENCE; STANDARD; TANDEM MASS SPECTROMETRY; ULTRAFILTRATION; ANIMAL; BLOOD; BLOOD ANALYSIS; CHEMISTRY; DESICCATION; DOG; INSTRUMENTATION; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY; MOUSE; PLASMA; RAT; TIME;

ANIMALS; BLOOD CHEMICAL ANALYSIS; BLOOD SPECIMEN COLLECTION; CHROMATOGRAPHY, LIQUID; DESICCATION; DOGS; DRUG STABILITY; GLUCURONATES; HUMANS; MICE; MYCOPHENOLIC ACID; PLASMA; RATS; REFERENCE STANDARDS; SPECIES SPECIFICITY; TANDEM MASS SPECTROMETRY; TIME FACTORS; ULTRAFILTRATION;

EID: 79953145539     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.10.99     Document Type: Article

References (22)

1. Shipkova M. Clinical utility of therapeutic drug monitoring of mycophenolic acid in transplantation medicine: where are we? J. Lab. Med. 33, 88-98 (2009).
2. Bullingham RE, Nicholls AG, Kamm BR. Clinical pharmacokinetics of mycophenolate mofetil. Clin. Pharmacokinet 34, 429-455 (1998). (Pubitemid 28273453)
3. Staatz CE, Tett SE. Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients. Clin. Pharmacokinet 46, 13-58 (2007). (Pubitemid 46091591)
4. Korecka M, Shaw LM. Review of the newest HPLC methods with mass spectrometry detection for determination of immunosuppressive drugs in clinical practice. Ann. Transplant. 14, 61-72 (2009).
5. Annesley TM, Clayton LT. Quantifcation of mycophenolic acid and glucuronide metabolite in human serum by HPLC-tandem mass spectrometry. Clin. Chem. 51, 872-877 (2005). (Pubitemid 40577924)
6. Di Francesco R, Frerichs V, Donnelly J, Hagler C, Hochreiter J, Tornatore KM. Simultaneous determination of cortisol, dexamethasone, methylprednisolone, prednisone, prednisolone, mycophenolic acid and mycophenolic acid glucuronide in human plasma utilizing liquid chromatography-tandem mass spectrometry J. Chromatogr. B 859, 42-51 (2007). (Pubitemid 47626087)
7. Djabarouti S, Duffau P, Xuereb F et al. Measurement of total and unbound mycophenolic acid and its glucuronide by LC coupled with MS. Application to a pharmacokinetic study of mycophenolate mofetil in patients with autoimmune diseases. Chromatographia 70, 939-945 (2009).
8. Streit F, Shipkova M, Armstrong VW, Oellerich M. Validation of a rapid and sensitive liquid chromatography-tandem mass spectrometry method for free and total mycophenolic acid. Clin. Chem. 50, 152-159 (2004). (Pubitemid 38125712)
9. Brandhorst G, Streit F, Goetze S, Oellerich M, Armstrong VW. Quantifcation by liquid chromatography tandem mass spectrometry of mycophenolic acid and its phenol and acyl glucuronide metabolites. Clin. Chem. 52, 1962-1964 (2006). (Pubitemid 44470706)
10. Ceglarek U, Caseta B, Lembcke J, Baumann S, Fiedler GM, Thiery J. Inclusion of MPA and in a rapid multi-drug LC-tandem mass spectrometric method for simultaneous determination of immunosuppressants. Clin. Chim. Acta. 373, 16 8-171 (2006).
11. Li W, Tse FLS. Dried blood spot sampling in combination with LC-MS/MS for quantitative analysis of small molecules. Biomed. Chromatogr. 24, 49-65 (2010).
12. Barfeld M, Spooner N, Lad R, Parry S, Fowles S. Application of dried blood spots combined with HPLC-MS/MS for the quantifcation of acetaminophen in toxicokinetic studies. J. Chromatogr. B. 870, 32-37 (2008).
13. Liang X, Li Y, Barfeld M, Ji QC. Study of dried blood spots techniques for the determination of dextromethorphan and its metabolite dextrorphan in human whole blood by LC-MS/MS. J. Chromatogr. B. 877, 799-806 (2009).
14. Spooner N, Lad R, Barfeld M. Dried blood spots as a sample collection technique for the determination of pharmacokinetics in clinical studies: considerations for the validation of a quantitative bioanalytical method. Anal. Chem. 81, 1557-1563 (2009).
15. Wilhelm AJ, den Burger JCG, Chahbouni A, Vos RM, Sinjewel A. Analysis of mycophenolic acid in dried blood spots using reversed phase high performance liquid chromatography. J. Chromatogr. B. 877, 3916-3919 (2009).
16. Heinig K, Bucheli F. Sensitive determination of oseltamivir and oseltamivir carboxylate in plasma, urine, cerebrospinal fuid and brain by liquid chromatography tandem mass spectrometry. J. Chromatogr. B. 876, 129-136 (2008).
17. Viswanathan CT, Bansal S, Booth B et al. Bioanalytical method validation and implementation: best practices for chromatographic and ligand binding assays. AAPS J. 9(1), E30-E38 (2007).
18. Savoie. N, Garofolo F, van Amsterdam P et al. White Paper on recent issues in regulated bioanalysis from the 3rd calibration and validation group workshop. Bioanalysis 2(1), 53-68 (2010).
19. Tsina I, Chu F et al. Manual and automated (robotic) high-performance liquid chromatography methods for the determination of mycophenolic acid and its glucuronide conjugate in human plasma. J. Chromatogr. B. 675, 119-129 (1996). (Pubitemid 26036976)
20. Timm U, Wall M, Dell D. A new approach for dealing with the stability of drugs in biological fuids. J. Pharm. Sci. 74, 972-977 (1985). (Pubitemid 15014141)
21. Xia Y-Q, Jemal M. Phospholipids in liquid chromatography/mass spectrometry bioanalysis: comparison of three tandem mass spectrometric techniques for monitoring plasma phospholipids, the effect of mobile phase composition on phospholipids elution and the association of phospholipids with matrix effects. Rapid Commun. Mass Spectrom. 23, 2125-2138 (2009).
22. Van Eeckhaut A, Lanckmans K, Sarre S, Smolders I, Michotte Y Validation of bioanalytical LC-MS/MS assays: evaluation of matrix effects. J. Chromatogr. B 877, 2198-2207 (2009).